Isabel Sánchez‐Ortega

2.8k total citations · 1 hit paper
50 papers, 1.1k citations indexed

About

Isabel Sánchez‐Ortega is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Isabel Sánchez‐Ortega has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 24 papers in Oncology and 18 papers in Epidemiology. Recurrent topics in Isabel Sánchez‐Ortega's work include Hematopoietic Stem Cell Transplantation (21 papers), Neutropenia and Cancer Infections (12 papers) and CAR-T cell therapy research (11 papers). Isabel Sánchez‐Ortega is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Neutropenia and Cancer Infections (12 papers) and CAR-T cell therapy research (11 papers). Isabel Sánchez‐Ortega collaborates with scholars based in Spain, Netherlands and Italy. Isabel Sánchez‐Ortega's co-authors include Rafael F. Duarte, Carlota Gudiol, Montserrat Arnán, Jordi Carratalà, Carolina García‐Vidal, Anna Sureda, Alberto Fernández de Sevilla, Beatriz Patiño, Josefina Ayats and M. Calvo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Isabel Sánchez‐Ortega

42 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

2022 159 citations John A. Snowden, Isabel Sánchez‐Ortega et al. Bone Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Sánchez‐Ortega Spain	17	454	404	374	326	133	50	1.1k
Montserrat Arnán Spain	19	469 1.0×	537 1.3×	242 0.6×	418 1.3×	69 0.5×	53	1.3k
Ilaria Caviglia Italy	18	513 1.1×	449 1.1×	143 0.4×	384 1.2×	78 0.6×	40	999
Domenico Pastore Italy	21	379 0.8×	205 0.5×	582 1.6×	119 0.4×	101 0.8×	66	1.3k
Mario Delia Italy	16	271 0.6×	246 0.6×	189 0.5×	180 0.6×	102 0.8×	48	824
Xaver Schiel Germany	19	570 1.3×	542 1.3×	134 0.4×	267 0.8×	133 1.0×	36	1.2k
Chiara Cattaneo Italy	25	1.3k 2.8×	553 1.4×	347 0.9×	387 1.2×	221 1.7×	102	2.2k
Noam Benyamini Israel	17	451 1.0×	144 0.4×	310 0.8×	289 0.9×	140 1.1×	53	963
Nack‐Gyun Chung South Korea	17	226 0.5×	167 0.4×	431 1.2×	116 0.4×	93 0.7×	117	1.0k
Hans‐Heinrich Wolf Germany	20	427 0.9×	480 1.2×	347 0.9×	465 1.4×	86 0.6×	42	1.3k
Roberta Di Blasi France	13	459 1.0×	181 0.4×	103 0.3×	133 0.4×	128 1.0×	41	762

Countries citing papers authored by Isabel Sánchez‐Ortega

Since Specialization

Citations

This map shows the geographic impact of Isabel Sánchez‐Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Sánchez‐Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Sánchez‐Ortega more than expected).

Fields of papers citing papers by Isabel Sánchez‐Ortega

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Sánchez‐Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Sánchez‐Ortega. The network helps show where Isabel Sánchez‐Ortega may publish in the future.

Co-authorship network of co-authors of Isabel Sánchez‐Ortega

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Sánchez‐Ortega. A scholar is included among the top collaborators of Isabel Sánchez‐Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Sánchez‐Ortega. Isabel Sánchez‐Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ortí, Guillermo, Guillaume Dachy, Charlotte Graham, et al.. (2025). Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee. Bone Marrow Transplantation. 60(6). 751–758. 2 indexed citations

Neofytos, Dionysios, Paul E. Verweij, Diana Averbuch, et al.. (2025). Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee. Current Research in Translational Medicine. 73(3). 103509–103509.

Battipaglia, Giorgia, Claudia Wehr, Rick Admiraal, et al.. (2025). Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee. Bone Marrow Transplantation. 61(2). 128–141.

Greco, Raffaella, Annalisa Ruggeri, Donal P. McLornan, et al.. (2025). Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations. Bone Marrow Transplantation. 60(11). 1499–1525.

Sanz, Jaime, Gesine Bug, Charles Craddock, et al.. (2025). Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee. The Lancet Oncology. 26(11). e586–e596.

Sánchez‐Guijo, Fermín, Joaquim Vives, Christian Chabannon, et al.. (2024). Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT). Cytotherapy. 26(7). 681–685. 10 indexed citations

Onida, Francesco, Nico Gagelmann, Yves Chalandon, et al.. (2024). Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee. Blood. 143(22). 2227–2244. 8 indexed citations

Yakoub‐Agha, Ibrahim, Raffaella Greco, Francesco Onida, et al.. (2023). Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation. 58(6). 696–700. 10 indexed citations

Worel, Nina, Per Ljungman, Nina Knelange, et al.. (2023). Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP). Bone Marrow Transplantation. 58(12). 1348–1356. 4 indexed citations

10.

Snowden, John A., Isabel Sánchez‐Ortega, Selim Corbacioglu, et al.. (2022). Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation. 57(8). 1217–1239. 159 indexed citations breakdown →

11.

Schoettler, Michelle Long, Enric Carreras, Byung‐Sik Cho, et al.. (2022). Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. Transplantation and Cellular Therapy. 29(3). 151–163. 60 indexed citations

12.

Snarski, Emilian, Jacqui Stringer, Małgorzata Mikulska, et al.. (2021). Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion—multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT. Bone Marrow Transplantation. 56(12). 2929–2933. 6 indexed citations

13.

Cid, Joan, Silvia Monsalvo, Cristina Pascual, et al.. (2021). Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH). Transfusion and Apheresis Science. 60(2). 103052–103052. 8 indexed citations

14.

Gudiol, Carlota, Manuela Aguilar‐Guisado, José Ramón Azanza Perea, et al.. (2019). Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies. Enfermedades Infecciosas y Microbiología Clínica. 38(4). 174–181. 18 indexed citations

15.

Ortí, Guillermo, Jaime Sanz, Irene García‐Cadenas, et al.. (2018). Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions. Experimental Hematology. 62. 24–32. 9 indexed citations

16.

Pomares, Helena, Montserrat Arnán, Isabel Sánchez‐Ortega, Anna Sureda, & Rafael F. Duarte. (2016). Invasive fungal infections in AML / MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?. Mycoses. 59(8). 516–519. 36 indexed citations

17.

Sánchez‐Ortega, Isabel, Rocío Parody, Octavio Servitje, et al.. (2016). Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease. Croatian Medical Journal. 57(3). 247–254. 10 indexed citations

18.

Kwon, Mi, Guiomar Bautista, Pascual Balsalobre, et al.. (2014). Haplo-Cord Transplantation Using CD34+ Cells from a Third-Party Donor to Speed Engraftment in High-Risk Patients with Hematologic Disorders. Biology of Blood and Marrow Transplantation. 20(12). 2015–2022. 33 indexed citations

19.

Sánchez‐Ortega, Isabel, Beatriz Patiño, Montserrat Arnán, et al.. (2013). Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation. Journal of Medical Economics. 16(6). 736–743. 4 indexed citations

20.

Valcárcel, David, Pau Montesinos, Isabel Sánchez‐Ortega, et al.. (2011). A scoring system to predict the risk of death during induction with anthracycline plus cytarabine‐based chemotherapy in patients with de novo acute myeloid leukemia. Cancer. 118(2). 410–417. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact